• Thioredoxin System Modulates CHK1 Inhibitor Sensitivity in N

  2026-07-28

  This study identifies the thioredoxin system as a key modulator of CHK1 inhibitor sensitivity in non-small cell lung cancer (NSCLC) by regulating ribonucleotide reductase activity through redox-dependent mechanisms. The findings reveal actionable targets for combination therapies aimed at improving efficacy while reducing toxicity in NSCLC treatment.

• GSK621 and AMPK: Unlocking Immunometabolic Pathways in AML

  2026-07-28

  Explore how GSK621, a potent AMPK agonist from APExBIO, empowers translational researchers to probe immunometabolic checkpoints in acute myeloid leukemia (AML) and beyond. This article synthesizes mechanistic insights from emerging literature with strategic protocol guidance, highlighting GSK621's role in modeling metabolic reprogramming, apoptosis induction, and the tumor microenvironment. Actionable recommendations and a forward-looking outlook underscore GSK621's unique value for next-generation metabolic and immunological research.

• Cefoperazone Sodium Salt: Optimizing Gram-Negative Assays

  2026-07-27

  Cefoperazone (sodium salt) offers researchers a robust, β-lactamase-stable tool for tackling antimicrobial assays with resistant gram-negative bacilli. This article details evidence-based workflows, protocol enhancements, and troubleshooting strategies that maximize reproducibility and impact in infection modeling and resistance studies.

• Fangchinoline Restores Lysosomal Biogenesis to Block H1N1

  2026-07-27

  The reference study identifies fangchinoline as a novel modulator of lysosomal biogenesis via TFEB activation, effectively counteracting H1N1 influenza infection. This work advances understanding of host-directed antiviral strategies by targeting lysosomal pathways, offering a mechanistic foundation for future therapeutic development.

• DAMGO in Mechanistic Pain Circuit Research: Protocols and In

  2026-07-26

  Explore how DAMGO, a selective µ-opioid receptor agonist, empowers advanced opioid receptor signaling research and pain circuit analysis. This article uniquely bridges molecular pharmacology with practical assay design, offering depth beyond existing resources.

• Haloprogin (BA1790): Reliable Antifungal for Lab Assays

  2026-07-25

  This article offers advanced, scenario-driven guidance for selecting and applying Haloprogin (SKU BA1790) in laboratory settings. By integrating validated MIC data, workflow parameters, and evidence-based vendor recommendations, it demonstrates how Haloprogin ensures reproducibility and sensitivity in antifungal and antimicrobial assays.

• Efficacy and Evidence of Antiseptics for Burns: A Review Ana

  2026-07-24

  The referenced Cochrane review systematically evaluates the comparative effectiveness of antiseptics and topical antibiotics for burn treatment, focusing on wound healing, infection prevention, and adverse outcomes. Rigorous meta-analyses reveal nuanced differences between silver dressings and antibiotic-based regimens, highlighting gaps in high-certainty evidence and directions for future research.

• Transmission Dynamics of Carbapenemase Genes in CREC (2022–2

  2026-07-24

  This study provides a comprehensive molecular characterization of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight teaching hospitals in Guangdong, China, during the COVID-19 pandemic. The findings reveal extensive plasmid-mediated dissemination of blaNDM-1 and multidrug resistance, underscoring urgent challenges for infection control and molecular tracking.

• Spatial Structuring in Ambrosia Beetle Nests Restricts Disea

  2026-07-23

  Masoudi et al. (2025) reveal that the spatial organization of social ambrosia beetle nests, alongside interactions with their symbiotic fungi, significantly limits the spread of infectious diseases, protecting vulnerable brood. Their integrative approach offers new insight into how social insects evolve colony-level mechanisms to buffer infection risks, with implications for broader studies in disease ecology and social immunity.

• Rapid Purification of Recombinant Annexin V for Biophysical

  2026-07-23

  This study introduces a streamlined, calcium-mediated purification protocol for recombinant annexin V, enabling high-purity protein isolation essential for structural and functional analyses. The method's efficiency addresses key challenges in obtaining uncontaminated annexin V for biophysical research and supports reproducible downstream assays.

• Standardizing Norepinephrine Reporting in Critical Care Rese

  2026-07-22

  Wieruszewski et al. (2024) confront widespread inconsistencies in norepinephrine formulation reporting, offering consensus guidance to ensure clarity and patient safety in critical care studies. Their position paper highlights the need for standardized terminology and dosage calculation, with direct impact on research reproducibility and clinical outcomes.

• Enhanced In Vitro Activity of Temafloxacin Against Gram-Posi

  2026-07-22

  This article examines the reference study's comprehensive analysis of Temafloxacin, a fluoroquinolone broad-spectrum antibacterial agent, highlighting its superior in vitro efficacy against Gram-positive pathogens compared to established quinolones. The findings have direct implications for antibacterial agent selection in research on resistant infections and assay development.

• Salvianolic Acid B Inhibits LH2 to Counter Pulmonary Fibrosi

  2026-07-21

  The referenced study identifies Salvianolic acid B as a potent inhibitor of lysyl hydroxylase 2 (LH2), effectively reducing collagen cross-linking and extracellular matrix stiffening in pulmonary fibrosis models. This mechanistic insight offers a targeted strategy for antifibrotic intervention and highlights new research directions for extracellular matrix remodeling in fibrotic lung disease.

• Azithromycin: Macrolide Antibiotic Workflows for Resistance

  2026-07-21

  Azithromycin stands out as a versatile macrolide antibiotic for modeling bacterial infection, resistance mechanisms, and trypanosomosis in animal studies. This guide details validated experimental workflows, troubleshooting insights, and protocol enhancements leveraging APExBIO's rigorously characterized compound.

• DOT1L Inhibition Enhances Lenalidomide Response in Myeloma

  2026-07-20

  The referenced study uncovers that inhibiting DOT1L, an epigenetic regulator, reprograms innate immunity in multiple myeloma and significantly potentiates the anti-myeloma activity of lenalidomide. These findings identify a novel mechanistic link between epigenetic regulation and immunomodulatory drug response, suggesting new avenues for combination therapies in hematologic malignancies.

15137 records 1/1010 page Next 12345 下5页 Last page